Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 359 across all filing types
Latest filing 2026-03-23 Audit Report / Informat…
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
사업보고서 (2025.12)
Audit Report / Information Classification · 92% confidence The document is titled "연결감사보고서" (Consolidated Audit Report) for the fiscal year ending December 31, 2025, issued by an independent auditor including audit opinion, basis for opinion, key audit matters, and full consolidated financial statements. It is a standalone audit report without narrative management discussion or full annual report text, fitting the definition of AR (Audit Report / Information). FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Moa Life Plus. It contains the meeting agenda, date, location, and details regarding voting procedures, including electronic voting. It also includes sections on board activities and business overviews, which are standard components of a proxy statement or notice of meeting package provided to shareholders to inform them of upcoming votes. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-16 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and proxy solicitation details. It also includes financial statements as part of the disclosure requirements for the meeting. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Moa Life Plus. It details the date, location, agenda items (such as financial statement approval, articles of incorporation changes, and director/auditor compensation), and specific business purpose changes. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2026-03-16 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital increase (유상증자결정) for the company Moa Life Plus. It details amendments to the payment date and listing date of new shares. This type of filing, which reports on changes to capital structure and share issuance, falls under the 'Share Issue/Capital Change' category.
2026-03-12 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '소액공모공시서류' (Small-scale Public Offering Disclosure Document) filed with the Financial Supervisory Service (FSS) in South Korea. It details a capital increase (issuance of new shares) through a third-party allocation method. This document serves as the primary disclosure for a small-scale public offering (under 1 billion KRW) where a full securities registration statement is not required. Based on the provided categories, this fits best as a 'Share Issue/Capital Change' (SHA) announcement, as it details the issuance of new shares, the capital amount, and the allocation process.
2026-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.